New $6M Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing
Genome Canada, the Ontario Institute for Cancer Research (OICR) and Thermo Fisher Scientific are collaborating to develop a complete solution of targeted next generation sequencing (NGS) assays and analysis software designed to more effectively assess cancer.